A double-blind, crossover, randomized comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint?
Chemotherapy
; 49(6): 316-23, 2003 Dec.
Article
em En
| MEDLINE
| ID: mdl-14671433
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Vômito
/
Benzimidazóis
/
Cisplatino
/
Satisfação do Paciente
/
Granisetron
/
Antieméticos
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2003
Tipo de documento:
Article